ARSENIC TRIOXIDE BLOCKED PROLIFERATION AND CARDIOMYOCYTE DIFFERENTIATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS: IMPLICATION IN CARDIAC DEVELOPMENTAL TOXICITYBAO, Z.,
HAN, Z.,
ZHANG, B.,
YU, Y.,
XU, Z.,
MA, W.,
DING, F.,
ZHANG, L.,
YU, M.,
LIU, S.,
JIN, M.,
YAN, G.,
HUANG, Q.,
WANG, X.,
HUA, B.,
YANG, F.,
LI, Y.,
LIU, Y.,
LI, B.,
WANG, N.,
CAI, B.,
ZAGIDULLIN, N.,
CARVALHO, K. ATOonhumancardiacdevelopmentbyusingavitrocardiacdifferentiationmodel ofhumaninducedpluripotentstemcells(hi
PSCs).Herewefoundthatclinicallyachievableconcentrations(0.1, 0.5 and 1μM) of ATO resulted in a
ARSENIC TRIOXIDE BLOCKED PROLIFERATION AND CARDIOMYOCYTE DIFFERENTIATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS: IMPLICATION IN CARDIAC DEVELOPMENTAL TOXICITYBAO, Z.,
HAN, Z.,
ZHANG, B.,
YU, Y.,
XU, Z.,
MA, W.,
DING, F.,
ZHANG, L.,
YU, M.,
LIU, S.,
JIN, M.,
YAN, G.,
HUANG, Q.,
WANG, X.,
HUA, B.,
YANG, F.,
LI, Y.,
LIU, Y.,
LI, B.,
WANG, N.,
CAI, B.,
ZAGIDULLIN, N.,
CARVALHO, K. ATOonhumancardiacdevelopmentbyusingavitrocardiacdifferentiationmodel ofhumaninducedpluripotentstemcells(hi
PSCs).Herewefoundthatclinicallyachievableconcentrations(0.1, 0.5 and 1μM) of ATO resulted in a